Latest News

  • PARTNERSHIPS

    16 Dec 2025

    Why Moderna’s Nanexa Pact Matters More Than It Looks
  • INNOVATION

    12 Dec 2025

    How Advanced Manufacturing Is Reshaping US Pharma
  • PARTNERSHIPS

    9 Dec 2025

    Halozyme Bets Big on the Future of Biologics Delivery
  • RESEARCH

    21 Nov 2025

    Why Drug Delivery Is the New Power Move

Can One Small Shot Last a Year? MIT Thinks So

MIT campus sign in front of the university’s main entrance with people walking past

INNOVATION

19 Nov 2025

A preclinical MIT injection draws growing attention from drugmakers

Microscopic view of cancer cells representing rise of injectable subcutaneous cancer therapies

MARKET TRENDS

16 Jun 2025

Fast-Track Cancer Care: Injections Replace IV Drips

Sanofi and Bristol Myers embrace subcutaneous delivery as infusion-based therapies give way to quicker, patient-friendly alternatives

Implant Could End Eye Drops: A New Era in Glaucoma Treatment

INVESTMENT

6 Jun 2025

Implant Could End Eye Drops: A New Era in Glaucoma Treatment

US start-up advances device replacing daily drops with sustained-release therapy

Scientists analyzing AI-driven drug research data in Persist AI’s automated cloud laboratory

TECHNOLOGY

31 May 2025

AI Cloud Labs Are Reshaping Drug Development Fast

Persist AI’s cloud lab speeds up drug R&D with AI and robotics, offering faster, cheaper formulation without traditional labs.

3D render of blue bioink cells showing Caltech’s ultrasound-based drug delivery innovation

INNOVATION

15 May 2025

Drug Delivery Without a Cut? Caltech’s Ultrasound Fix

Ultrasound-triggered implants may reduce need for surgery and reshape future of targeted therapy

Ajinomoto Bio-Pharma Services building acquired by PCI Pharma for US biotech expansion

PARTNERSHIPS

9 May 2025

From mRNA to ADCs: PCI Bets Big on Biotech Boom

Pharma firm PCI buys Althea site to boost US production of next-gen injectables like ADCs and mRNA therapies.

USP building symbolizing global drug purity standards reform

REGULATORY

2 May 2025

Drug Purity Rules Get a Global Upgrade

USP’s 2026 standards push pharma to modernize impurity testing

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.